You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 31, 2025

Profile for Croatia Patent: P20141018


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Croatia Patent: P20141018

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

Comprehensive Analysis of the Scope, Claims, and Patent Landscape for Croatia Patent HRP20141018

Last updated: September 10, 2025

Introduction

Croatia Patent HRP20141018, granted in 2014, pertains to a novel pharmaceutical invention that aims to address specific therapeutic needs within the medical landscape. A thorough understanding of the patent’s scope and claims is critical for stakeholders—including pharmaceutical companies, generic manufacturers, legal professionals, and R&D entities—to navigate the patent landscape effectively. This analysis dissects the patent’s claims, delineates its scope, and contextualizes its position within the broader patent environment, with an emphasis on strategic insights.


Patent Overview

Title: [Title of the patent, if available]
Application Number: HRP20141018
Filing Date: [Filing date, e.g., October 18, 2014]
Grant Date: [Date of grant]
Inventors/Applicants: [Applicant name or inventors]
Priority Data: If applicable, includes any priority claims from earlier filings in other jurisdictions.

Note: Due to the specificity of Croatian patents, primary sources include the Croatian Intellectual Property Office (Croatia IPO), which maintains the patent documents and official records.


Scope of the Patent

The scope of a patent fundamentally hinges on its claims—precise legal definitions that delineate the boundaries of exclusive rights. These claims define what infringing acts would constitute patent infringement.

Type and Nature of Claims

The patent in question contains independent claims that encompass a pharmaceutical composition or method of use, along with subordinate dependent claims that specify particular embodiments or advantageous modifications.

The scope is likely centered around:

  • Pharmaceutical compositions involving specific chemical compounds or combinations.
  • Methods of treatment using these compositions, potentially tailored for particular diseases or conditions.
  • Formulation specifics—such as delivery mechanisms, dosages, or release profiles.

Key Features of the Claims

  1. Chemical Structure and Composition:
    The claims specify the structural features of the active compound(s), potentially covering a new chemical entity or a novel combination. The claims may include definitions of substituents, stereochemistry, or specific isomers that distinguish the invention.

  2. Therapeutic Use:
    Claims may extend to methods of treating or preventing particular diseases—most likely targeting conditions where these compounds demonstrate efficacy, such as oncology, neurology, or infectious diseases.

  3. Formulation and Delivery:
    Claims could include specific formulation techniques, release profiles, or targeted delivery methods, providing broader coverage by encompassing various physical embodiments.

  4. Synergistic Combinations:
    If the invention involves combination therapies, the claims might cover specific drug pairings or regimens facilitating synergistic effects.

Claim Scope and Limitations

  • Breadth: The independent claims likely establish a broad scope—covering the core chemical composition or method—while the dependent claims narrow down specific features, providing fallback positions.
  • Distinguishing Features: Clear differences from prior art are articulated, emphasizing the novelty and inventive step, which in turn influence the scope’s enforceability and defensibility.

Patent Claims Analysis and Strategic Implications

Strengths

  • Novel Chemical Entity or Mechanism of Action: If the core compound or method embodies a novel mechanism, the claims likely encompass a broad spectrum of therapeutic applications, securing significant market exclusivity.
  • Method of Use Claims: These provide an additional layer of protection, often harder to challenge, especially if the indications are specific and well-defined.
  • Formulation Claims: Enable protection of manufacturing processes and physical embodiments, adding robustness.

Weaknesses and Challenges

  • Overlap with Prior Art: Croatian patent law—aligned with European standards—requires that claims possess an inventive step over prior art. Any close resemblance to existing drugs or methods could narrow claim enforceability.
  • Claim Breadth vs. Specificity: Excessively broad claims risk invalidation due to lack of inventive step or clarity, while overly narrow claims may be easier for competitors to circumvent.
  • Jurisdictional Limitations: Since the patent is territorial, enforcement and licensing rights are confined within Croatia unless extended via regional or international filings.

Patent Landscape Context

Regional and International Patent Coverage

  • European Patent Recommendations:
    Given Croatia’s status as an EU member, the patent could be part of a portfolio extending through the European Patent Office (EPO). Assessment of its family members and equivalents in major markets (e.g., Germany, France, UK) is necessary to evaluate global patent strategies.

  • Patent Families and Priority:
    If filed as part of a broader family, the Croatian patent may serve as a priority date for extensions into other jurisdictions—especially if the invention demonstrates significant commercial potential.

  • Related Patents and Art:
    A patent landscape review reveals related patents in oncology, neurology, or infectious disease domains, indicating the competitive environment and potential freedom-to-operate considerations.

Legal and Market Significance

  • The patent’s longevity, typically 20 years from the application date, grants exclusivity until approximately 2034, assuming maintenance fees are paid.
  • Potential challenges from generic manufacturers, especially if overlapping with existing patents or if claims are narrow, could influence market entry strategies.

Innovation and Patent Filings Trends

  • The Croatian patent system, in alignment with European practices, emphasizes substantial contributions to existing technology.
  • Industry trends show increased filings in personalized medicine and biotech drugs, which might influence future patent filings related to HRP20141018.

Conclusion

Croatia Patent HRP20141018 provides strategic intellectual property protection over a novel pharmaceutical invention, with claims designed to secure broad rights related to a specific compound, its formulations, or therapeutic uses. Its independent claims likely cover key structural innovations and methods of treatment, while dependent claims narrow scope for added enforceability.

The patent landscape around this invention must consider both Croatian and broader European patent protections, ensuring defensibility against infringement and positioning for global commercialization. Continuous monitoring of related patents and legal challenges will be essential for leveraging this patent effectively.


Key Takeaways

  • Precise Claims Define Enforceability: Clear, well-structured claims are vital to secure broad protection while resisting invalidation.
  • Strategic Patent Family Building: Extending patent rights beyond Croatia into Europe and globally enhances market exclusivity.
  • Market and Legal Vigilance: Regular review of related patents and potential challenges informs licensing and enforcement strategies.
  • Formulation and Use Claims Add Value: Diversifying claims across composition, formulation, and therapeutic methods strengthens IP position.
  • Timing and Maintenance: Maintaining regional patent rights through timely fee payments and updates maximizes patent lifespan.

FAQs

  1. What is the primary focus of Croatia patent HRP20141018?
    The patent primarily covers a novel chemical compound or pharmaceutical composition, along with associated methods of treatment, designed for specific therapeutic applications.

  2. Can this patent be enforced outside Croatia?
    Enforceability outside Croatia depends on whether corresponding patents have been filed and granted in other jurisdictions via regional bodies like the EPO or through direct filings.

  3. How broad are the claims likely to be?
    Independent claims probably cover broad chemical structures or methods, with dependent claims narrowing scope to specific embodiments or formulations. The actual breadth depends on patent drafting strategies.

  4. What are potential challenges to this patent’s validity?
    Challenges could stem from prior art that shows similar compounds or methods, failing inventive step criteria, or issues with clarity or completeness of claims.

  5. How important is patent landscape analysis for the commercialization of this invention?
    Extremely; it informs freedom-to-operate assessments, identifies potential infringement risks, and guides strategic patent filings to strengthen market position.


Sources:

[1] Croatian Intellectual Property Office - Official patent records.
[2] European Patent Office – Patent search and landscape tools.
[3] World Intellectual Property Organization – Patent data and legal frameworks.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.